Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TrkB agonist antibodies and methods for treating an ocular degenerative disorder characterized by degeneration of retinal ganglion cells (RGCs)

TrkB agonist antibodies and methods for treating an ocular degenerative disorder characterized by degeneration of retinal ganglion cells (RGCs)

US Patent 10975152 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antenna structure and wireless communication device having same2025
Antenna structure and wireless communication device using same2024
Articles and methods directed to personalized therapy of cancer2024
Articles and methods directed to personalized therapy of cancer2024
Antenna structure and wireless communication device2022
Articles and methods directed to personalized therapy of cancer2022
Articles and methods directed to personalized therapy of cancer2022
Methods and compositions related to functional polypeptides embedded in heterolo2021
Methods and compositions related to functional polypeptides embedded in heterolo2021
Methods and compositions related to GPCR agonist polypeptides2020
Methods and compositions related to GPCR agonist polypeptides2020
Proximity based methods for selection of binding partners2020